frontotemporal lobar dementia

Yumanity and Merck Ink $500 Million+ Deal for Neurodegenerative Diseases
BioSpace
Wed, 06/24/20 - 10:28 am
Yumanity Therapeutics
Merck
ALS
frontotemporal lobar dementia
R&D